ACADIA Pharmaceuticals(ACAD) - 2024 Q1 - Earnings Call Presentation

First Quarter 2024 Earnings Call May 8, 2024 Call Agenda Welcome Al Kildani | Senior Vice President, Investor Relations and Corporate Communications CEO Opening Remarks Steve Davis | President and Chief Executive Officer Commercial Update Brendan Teehan | Chief Operating Officer, Head of Commercial R&D Update Kimberly Manhard | Senior Vice President, Global Strategic Planning and Execution Financial Update Mark Schneyer | Chief Financial Officer Closing Remarks Steve Davis | President and Chief Executive Of ...